The Institute of Antiviral Research at Utah State University has compared the antiviral efficacy of four oral rinses in collaboration with IoTech International.
The testing included two rinses recommended by the ADA in its interim COVID-19 guidance (1.5% hydrogen peroxide and 0.2% povidone iodine). It also included an oral rinse that had earned the ADA Seal of Acceptance (0.12% chlorhexidine gluconate) and a molecular iodine oral rinse being developed by IoTech International.
To view the full story, please click here.
To view more COVID-19 news as it pertains to the dental profession, please click here.
